Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

611 questions in 50 reviews · Injuries

current versions
No studies 125 · 20.5%Ungraded 22 · 3.6%Very low 185 · 30.3%Low 171 · 28%Moderate 77 · 12.6%High 31 · 5.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Intervention NR
A reduction from 66% to 35% in the percentage of speeding drivers at experimental sites compared to before period.
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRLow
Acetaminophen plus Diphenhydramine vs placebo
Febrile reactions (fever with or without chills, chills with or without rigors) ‐ Intention‐to treat analysis · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0.52 [0.21, 1.25]1 study · 334 participantsLow
Acetaminophen plus Diphenhydrammine vs placebo (Unit of randomisation: transfusion)
Adverse events · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0 [0, 0]0 studies · 0 participantsUngraded
Acetaminophen plus Diphenhydramine vs placebo
Anaphylatic reactions ‐ not reported · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0 [0, 0]0 studies · 0 participantsUngraded
Acetaminophen plus Diphenhydramine vs placebo
Death ‐ not reported · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0 [0, 0]0 studies · 0 participantsUngraded
Acetaminophen plus Diphenhydramine vs placebo
Adverse events · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0 [0, 0]0 studies · 0 participantsUngraded
Acetaminophen plus Diphenhydramine vs placebo
Allergic reactions (urticaria with or without pruritus) ‐ Intention‐to treat analysis · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 1.45 [0.78, 2.72]1 study · 334 participantsVery low
Acetaminophen plus Diphenhydrammine vs placebo (Unit of randomisation: transfusion)
Fever ‐ Per protocol analysis · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 1.77 [0.57, 5.49]1 study · 98 participantsLow
Acetaminophen plus Diphenhydrammine vs placebo (Unit of randomisation: transfusion)
Anaphylatic reactions ‐ not reported · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0 [0, 0]0 studies · 0 participantsUngraded
Acetaminophen plus Diphenhydrammine vs placebo (Unit of randomisation: transfusion)
Hives ‐ Per protocol analysis · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0.13 [0.01, 2.39]1 study · 98 participantsLow
Acetaminophen plus Diphenhydrammine vs placebo (Unit of randomisation: transfusion)
Death ‐ not reported · patients with requirement of prophylaxis to avoid allergic and febrile non‐haemolytic transfusion reactions
Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions (2010) · Cochrane
RR 0 [0, 0]0 studies · 0 participantsUngraded